课题基金 / 基金详情

Cutaneous Adverse Drug Reactions

Cutaneous Adverse Drug Reactions
皮肤药物不良反应
批准号：
8763275
负责人：
Heidi Kong
金额：
$3.28万
依托单位：
DIVISION OF BASIC SCIENCES - NCI
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/8763275
关键词：
Adverse effectsAntineoplastic AgentsAppearanceBAY 54-9085ClinicClinicalClinical TrialsCommunitiesConsultCutaneousDermatologicDermatologyDevelopmentDiagnosisDoseDrug toxicityEvaluationGoalsKnowledgeLifeMediatingMethodsMonitorNational Cancer InstitutePainPalmar-plantar erythrodysesthesia syndromePathogenesisPatientsPharmaceutical PreparationsProtocols documentationReactionRecording of previous eventsResearchRiskSkinTimeToxic effectTreatment ProtocolsUnited States National Institutes of HealthVisitWorkbasedesignexperiencefollow-upimprovednoveloncology

项目摘要

项目成果

Heidi Kong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In fiscal year 2013, we continued to evaluate oncology patients at risk for the development of cutaneous toxicities associated with molecularly targeted therapies. These evaluations included baseline evaluations prior to initiation of treatment and follow-up visits to monitor and treat these skin toxicities. We work with oncology colleagues to optimally design treatment protocols to evaluate for cutaneous toxicities and to inform the research community of potentially newly described skin toxicities and methods for management of these adverse effects to optimize continued antineoplastic treatment of oncology patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of systemic and topical perturbations on human microbes
Botulinum Toxin for Painful Cutaneous Leiomyomas
Gene Expression Profiling and Clinical Characterization of Phototoxicity
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients
海外基金